[1]
|
Bonnans J F, Gilbert J C, Lemarechal C, Sagastizabal C. Numerical Optimization: Theoretical and Practical Aspects. Springer-Verlag, 2006[2] Lanckriet G R G, Cristianini N, Bartlett P, Ghaoui L E, Jordan M I. Learning the kernel matrix with semidefinite programming. Journal of Machine Learning Research, 2004, 5. 27-72[3] Bach F R, Lanckriet G R G, Jordan M I. Multiple kernel learning, conic duality, and the SMO algorithm. In: Proceedings of the 21st International Conference on Machine Learning. New York, USA: ACM 2004. 1-8[4] Kimeldor G S, Wahba G. Some results on tchebycheffian spline functions. Journal of Mathematical Analysis and Applications, 1971, 33(1): 82-95 [5] Schlkopf B, Smola A. Learning with kernels: support vector machines, regularization, optimization, and beyond. Cambridge: The MIT Press, 2002[6] Tibshirani R. Regression shrinkage and selection via the Lasso. Journal of the Royal Statistical Society Series B-Statistical Methodology, 1996, 58(1): 267-288[7] Zou H, Hastie T. Regularization and variable selection via the elastic net. Journal of the Royal Statistical Society Series B-Statistical Methodology, 2005, 67: 301-320[8] Micchelli C A, Pontil M. Learning the kernel function via regularization. Journal of Machine Learning Research, 2005, 6: 1099-1125[9] Rakotomamonjy A, Bach F R, Canu S, Grandvalet Y. SimpleMKL. Journal of Machine Learning Research, 2008, 9: 2491-2521[10] Bonnans J F, Shapiro A. Optimization problems with perturbations: A guided tour. Siam Review, 1998, 40(2): 228-264[11] Sturm J F. Using SeDuMi 1.02, a MATLAB toolbox for optimization over symmetric cones. Optimization Methods Software, 1999, 11: 625-653[12] Hess K R, Anderson K, Symmans W F, Valero V, Ibrahim N, Mejia J, et al. Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer. Journal of Clinical Oncology, 2006, 24(26): 4236-4244[13] Fumoleau P, Campone M, Coudert B, Mayer F, Favier L, Ferrant E. Targeting ErbB receptors in breast cancer. Bullitin du Cancer, 2007, 94, F147-170[14] Bando H. Vascular endothelial growth factor and bevacitumab in breast cancer. Breast Cancer, 2007, 14(2): 163-173[15] Buck M B, Knabbe C. TGF-beta signaling in breast cancer. Annals of the New York Academy of Sciences, 2006, , 119-126[16] Hancox R A, Allen M D, Holliday D L, Edwards D R, Pennington C, Guttery D S, et al. Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms. Breast Cancer Research, 2009, 11(2): 1-13[17] Ilvesaro J M, Merrell M A, Li L, Wakchoure S, Graves D, Brooks S, et al. Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion. Molecular Cancer Research, 2008, (10): 1534-1543[18] Jing J, Tarbutton E, Wilson G, Prekeris R. Rab11-FIP3 is a Rab11-binding protein that regulates breast cancer cell motility by modulating the actin cytoskeleton. European Journal of Cell Biology, 2009, 88(6): 325-341[19] Kloft M, Brefeld U, Laskov P, Sonnenburg S. Non-sparse multiple kernel learning. In: Proceedings of the Neural Information Processing Systems Workshop Vancouver, Canada: Curran Associatos, 2008. 1-4[20] Efron B, Hastie T, Johnstone I, Tibshirani R. Least angle regression. Annals of Statistics, 2004, 32(2): 407-451
|